department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

ATOSSA THERAPEUTICS, INC. ($ATOS) · pharmadog

PUBLIC COMPANY

$ATOSATOSSA THERAPEUTICS, INC.

Seattle, WA, USupdated 1mo ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

1

marketed

0

phase 3

0

catalysts ytd

0

approvals ytd

0

recalls ytd

0

Pipeline(1)

pipeline depth1 products

1Phase 2

Human Epidermal Growth Factor Receptor 2 Negative Breast…

Upcoming

no upcoming catalysts on record

Recent(90d)

nothing in the last 90 days

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view ATOSSA THERAPEUTICS, INC. jobs →

News

no news has mentioned this company yet

identifiers

ticker

$ATOS

SEC CIK

0001488039

country

US

source

sec_tickers

top tags

mentioned in

0news items

entity-linker matched

$ATOS

Active trials

phase2(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancerrecruitingn=87
phase2Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Densityactive not recruitingn=240
phase2A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrantterminatedn=3
—The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavagecompletedn=6

Data sources

last refreshed 37m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Insider activity

source: SEC Form 4

routine RSU / option mechanics (2)

Mar 27, 26grantQUAY STEVEN C · President & CEO65,000 sh
Mar 26, 26grantDaniel Mark James · Chief Financial Officer63,000 sh

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?